Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT07451366 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-03-06
Summary
Our study will assess the prevalence of obesity among patients with (MASLD) and to evaluate the characteristics of lean MAFLD patients.
Conditions
- Lean MASLD
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2026-12-01
- Completion
- 2027-07-01
More Related Trials
-
Impact of Weight Loss in Cirrhosis With Obesity and MAFLD
NCT05104541 ·Status: UNKNOWN ·Phase: NA
-
New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
NCT06647095 ·Status: COMPLETED
-
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China
NCT04573283 ·Status: RECRUITING
-
Fatty Liver Disease Collaborative Research in China
NCT02391168 ·Status: UNKNOWN
-
The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods
NCT06061640 ·Status: UNKNOWN
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
NCT06843421 ·Status: NOT_YET_RECRUITING
-
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218 ·Status: UNKNOWN
-
Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease
NCT06135467 ·Status: NOT_YET_RECRUITING
-
De Novo Lipogenesis in Severity of NAFLD
NCT03683589 ·Status: COMPLETED
-
Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting
NCT05880316 ·Status: UNKNOWN ·Phase: NA
-
Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver
NCT02669316 ·Status: COMPLETED
-
Clinical Characteristics of Metabolic Associated Fatty Liver Disease
NCT06325254 ·Status: RECRUITING
-
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00983463 ·Status: ENROLLING_BY_INVITATION
-
A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD
NCT07233486 ·Status: RECRUITING ·Phase: NA
-
Obesity Phenotypes and Its Relation to Cardiovascular Diseases
NCT06092021 ·Status: NOT_YET_RECRUITING
-
Liver Health and Metabolic Function in People With Obesity
NCT03701828 ·Status: COMPLETED ·Phase: NA
-
A Nutrigenetic Intervention in MASLD
NCT06220695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
NCT06009250 ·Status: UNKNOWN
-
Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease
NCT05554224 ·Status: RECRUITING
-
MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes
NCT04761900 ·Status: COMPLETED
-
Metabonomic of Patients With Hepatitis B Cirrhosis Complicated With Sarcopenia.
NCT05041348 ·Status: COMPLETED
-
Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)
NCT07330830 ·Status: RECRUITING
-
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
NCT04059029 ·Status: UNKNOWN
-
Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study
NCT04440540 ·Status: TERMINATED ·Phase: NA